JAY JEFFREY R
13F Reported Value
ⓘ$126,545
incl. option notional
Equity Holdings
ⓘ$120,483
Option Notional
ⓘ$6,062
$4,872 puts / $1,190 calls
Holdings
32
Latest Filing
2013-06-30
Filing Quarter
Q2 2013
Portfolio Overview
JAY JEFFREY R disclosed 32 positions worth $126,545 in its Form 13F-HR for Q2 2013 — $120,483 in common stock plus $6,062 of put/call option positions (reported at underlying notional value, not premium at risk). During the quarter the fund opened 32 new positions and exited 0. The portfolio is most concentrated in Other (90.4% of disclosed assets). All figures are sourced directly from JAY JEFFREY R’s Form 13F-HR filing with the SEC under CIK 1239607.
Sector Allocation
13fpro.ai/research/fund/jay-jeffrey-r-1239607
Top Equity Holdings by Value
13fpro.ai/research/fund/jay-jeffrey-r-1239607
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2013
Click any card to unlockTop Holdings
HYPERION THERAPEUTICS INC. - COM
—Quality
$21.2K963,961 shFURIEX PHARMACEUTICAL, INC. - COM
—Quality
$16.8K494,100 shSTEMLINE THERAPEUTICS INC. - COM
—Quality
$14.2K595,493 shBIODEL INC. - COM
—Quality
$7.7K1,853,845 shAMBIT BIOSCIENCES CORP - COM
—Quality
$7.0K1,000,000 sh- —
Quality
$5.6K3,750,000 sh PAIN THERAPEUTICS INC. - COM
—Quality
$5.1K2,322,769 shSUNSHINE HEART INC. - COM
—Quality
$5.1K950,000 shDURATA THERAPEUTICS INC. - COM
—Quality
$4.6K639,433 shNORDION INC. - COM
—Quality
$4.0K537,500 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| HYPERION THERAPEUTICS INC. - COM | — | $21.2K | 963,961 |
| FURIEX PHARMACEUTICAL, INC. - COM | — | $16.8K | 494,100 |
| STEMLINE THERAPEUTICS INC. - COM | — | $14.2K | 595,493 |
| BIODEL INC. - COM | — | $7.7K | 1,853,845 |
| AMBIT BIOSCIENCES CORP - COM | — | $7.0K | 1,000,000 |
| — | $5.6K | 3,750,000 | |
| PAIN THERAPEUTICS INC. - COM | — | $5.1K | 2,322,769 |
| SUNSHINE HEART INC. - COM | — | $5.1K | 950,000 |
| DURATA THERAPEUTICS INC. - COM | — | $4.6K | 639,433 |
| NORDION INC. - COM | — | $4.0K | 537,500 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of JAY JEFFREY R's 32 positions.
Showing top 10 of 32 holdings.
Sector Allocation
Other
$108,924
Healthcare
$11,559
Full Holdings — JAY JEFFREY R (Q2 2013)
All 32 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | HYPERION THERAPEUTICS INC. - COM | $21,207 | 17.6% | NEW | — |
| 2 | — | FURIEX PHARMACEUTICAL, INC. - COM | $16,834 | 14.0% | NEW | — |
| 3 | — | STEMLINE THERAPEUTICS INC. - COM | $14,196 | 11.8% | NEW | — |
| 4 | — | BIODEL INC. - COM | $7,749 | 6.4% | NEW | — |
| 5 | — | AMBIT BIOSCIENCES CORP - COM | $7,000 | 5.8% | NEW | — |
| 6 | GERON CORP | $5,625 | 4.7% | NEW | — | |
| 7 | — | PAIN THERAPEUTICS INC. - COM | $5,133 | 4.3% | NEW | — |
| 8 | — | SUNSHINE HEART INC. - COM | $5,101 | 4.2% | NEW | — |
| 9 | — | DURATA THERAPEUTICS INC. - COM | $4,604 | 3.8% | NEW | — |
| 10 | — | NORDION INC. - COM | $3,978 | 3.3% | NEW | — |
| 11 | — | HORIZON PHARMA, INC. - COM | $3,928 | 3.3% | NEW | — |
| 12 | — | ONCOGENEX PHARMACEUTICAL INC. - COM | $3,401 | 2.8% | NEW | — |
| 13 | — | IMPAX LABORATORIES, INC. - COM | $2,991 | — | NEW | — |
| 14 | TRINITY BIOTECH PLC | $2,749 | 2.3% | NEW | — | |
| 15 | — | RTI BIOLOGICS, INC. - COM | $2,534 | 2.1% | NEW | — |
| 16 | — | DYAX CORP - COM | $2,519 | 2.1% | NEW | — |
| 17 | — | MAST THERAPEUTICS INC. - COM | $2,490 | 2.1% | NEW | — |
| 18 | Protalix BioTherapeutics, Inc. | $1,959 | 1.6% | NEW | 57.8 | |
| 19 | MYRIAD GENETICS INC | $1,881 | — | NEW | 24.3 | |
| 20 | — | VOLCANO CORPORATION - COM | $1,813 | 1.5% | NEW | — |
| 21 | — | TARGACEPT, INC. - COM | $1,570 | 1.3% | NEW | — |
| 22 | — | AVANIR PHARMACEUTICALS INC. - CL A NEW | $1,190 | — | NEW | — |
| 23 | — | XENOPORT INC. - COM | $1,153 | 1.0% | NEW | — |
| 24 | — | MEI PHARMA INC. - COM NEW | $1,124 | 0.9% | NEW | — |
| 25 | — | PERNIX THERAPEUTICS HOLDINGS - COM | $1,073 | 0.9% | NEW | — |
| 26 | PALATIN TECHNOLOGIES INC | $1,062 | 0.9% | NEW | — | |
| 27 | — | VASCULAR SOLUTIONS INC. - COM | $680 | 0.6% | NEW | — |
| 28 | — | WRIGHT MEDICAL GROUP, INC. - RIGHT 03/01/2019 | $542 | 0.5% | NEW | — |
| 29 | — | CELSION CORPORATION - COM | $190 | 0.2% | NEW | — |
| 30 | ARTIVION, INC. | $164 | 0.1% | NEW | 47.8 | |
| 31 | — | GW PHARMACEUTICALS PLC - ADS | $102 | 0.1% | NEW | — |
| 32 | — | AMAG PHARMACEUTICALS, INC. - COM | $3 | 0.0% | NEW | — |
New Positions (32)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for JAY JEFFREY R including:
Track JAY JEFFREY R's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for JAY JEFFREY R and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: JAY JEFFREY R
13F Pro is an AI hedge fund tracker and stock research platform. For JAY JEFFREY R (SEC CIK: 1239607), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in JAY JEFFREY R's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.